Fidelity Disruptive Medicine Fund is a registered fund series of Fidelity Summer Street Trust (series S000067934). Net assets $43.2M as of 2023-05-31.
Showing 15 of 68 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | — | $1.9M | 447.33% |
| UNITEDHEALTH GROUP INC | — | $1.7M | 400.84% |
| HUMANA INC | — | $1.7M | 387.91% |
| PENUMBRA INC | — | $1.6M | 364.90% |
| VERTEX PHARMACEUTICALS INC | — | $1.6M | 362.76% |
| LILLY (ELI) and CO | — | $1.5M | 355.59% |
| INSULET CORP | — | $1.5M | 338.75% |
| DANAHER CORP | — | $1.4M | 319.96% |
| ROYALTY PHARMA PLC | — | $1.4M | 314.75% |
| MASIMO CORP | — | $1.3M | 292.46% |
| CENTENE CORP DEL | — | $1.3M | 290.55% |
| BRUKER CORP | — | $1.2M | 279.34% |
| ARGENX SE | — | $1.1M | 253.32% |
| ALNYLAM PHARMACEUTICALS INC | — | $1.1M | 246.28% |
| 10X GENOMICS INC | — | $992K | 229.60% |
| Report date | Net assets |
|---|---|
| 2023-05-31 | $43.2M |
| 2023-02-28 | $42.1M |
| 2022-11-30 | $48.6M |
| 2022-08-31 | $55.8M |
| 2022-05-31 | $52.3M |
| 2022-02-28 | $66.9M |
| 2021-11-30 | $80.3M |
| 2021-08-31 | $82.2M |